Popovici, D.; Stanisav, C.; Sima, L.V.; Negru, A.; Murg, S.I.; Carabineanu, A.
Influence of Biomarkers on Mortality among Patients with Hepatic Metastasis of Colorectal Cancer Treated with FOLFOX/CAPOX and FOLFIRI/CAPIRI, Including Anti-EGFR and Anti-VEGF Therapies. Medicina 2024, 60, 1003.
https://doi.org/10.3390/medicina60061003
AMA Style
Popovici D, Stanisav C, Sima LV, Negru A, Murg SI, Carabineanu A.
Influence of Biomarkers on Mortality among Patients with Hepatic Metastasis of Colorectal Cancer Treated with FOLFOX/CAPOX and FOLFIRI/CAPIRI, Including Anti-EGFR and Anti-VEGF Therapies. Medicina. 2024; 60(6):1003.
https://doi.org/10.3390/medicina60061003
Chicago/Turabian Style
Popovici, Dorel, Cristian Stanisav, Laurentiu V. Sima, Alina Negru, Sergiu Ioan Murg, and Adrian Carabineanu.
2024. "Influence of Biomarkers on Mortality among Patients with Hepatic Metastasis of Colorectal Cancer Treated with FOLFOX/CAPOX and FOLFIRI/CAPIRI, Including Anti-EGFR and Anti-VEGF Therapies" Medicina 60, no. 6: 1003.
https://doi.org/10.3390/medicina60061003
APA Style
Popovici, D., Stanisav, C., Sima, L. V., Negru, A., Murg, S. I., & Carabineanu, A.
(2024). Influence of Biomarkers on Mortality among Patients with Hepatic Metastasis of Colorectal Cancer Treated with FOLFOX/CAPOX and FOLFIRI/CAPIRI, Including Anti-EGFR and Anti-VEGF Therapies. Medicina, 60(6), 1003.
https://doi.org/10.3390/medicina60061003